Evidence map›Paper›PMID 41264372›Full record

ArticleClinical journal of the American Society of Nephrology : CJASN2026

Sex Differences in Dementia and Mild Cognitive Impairment in Nondialysis CKD.

Ester S Oh, Gilda Opoku, Sanna Darvish, Daniel H Craighead, Anna Ostrow, Matthew J Rossman, Cortney N Steele, Taylor Struemph, Zhiying You, Douglas R Seals and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04040959 (Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04040959 phase2active not recruitingnot on this map

Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD

TypeinterventionalSponsorUniversity of Colorado, DenverRan2019 to 2027Enrolled118ConditionsVascular Diseases, Kidney Disease, Blood Pressure, Oxidative StressArmsNicotinamide riboside
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ester S OhDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0003-4942-0762
Gilda OpokuIntegrated Physiology (IPHY) Graduate Program, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0003-4599-8903
Sanna DarvishDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado.ORCID 0009-0009-8923-3305
Daniel H CraigheadDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado.ORCID 0000-0002-8744-5349
Anna OstrowDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Matthew J RossmanDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado.ORCID 0000-0001-9381-2590
Cortney N SteeleDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0002-5701-1240
Taylor StruemphDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Zhiying YouDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0002-7483-2809
Douglas R SealsDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, Colorado.
Michel ChoncholDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Kristen L NowakDivision of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado.ORCID 0000-0001-9364-3256

Funding

Colorado Clinical and Translational Sciences Institute (CCTSI)UM1TR004399 · NCATS · UNIVERSITY OF COLORADO DENVER · PI JANINE A HIGGINS, RONALD J. SOKOL · 2023 to 2026
$30.7M
TRAINING IN RENAL &ELECTROLYTE DISEASE &HYPERTENSIONT32DK007135 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JOHNSON, RICHARD JOSEPH, KENDRICK, JESSICA B · 1986 to 2024
$5.3M
Mitochondrial-targeted antioxidant supplementation for improving vascular endothelial function inpostmenopausal women: comparison with standard-of-care exerciseR01AG066730 · NIA · UNIVERSITY OF COLORADO · PI Matthew J Rossman, DOUGLAS R SEALS · 2021 to 2026
$4.0M
Inspiratory muscle strength training for lowering systolic blood pressure in midlife and older adults with chronic kidney diseaseR01DK130266 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CHONCHOL, MICHEL BENJAMIN, NOWAK, KRISTEN LYNN · 2021 to 2025
$2.8M
Nicotinamide riboside supplementation for treating arterial stiffness and elevated systolic blood pressure in patients with moderate to severe CKD.R01DK121516 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CHONCHOL, MICHEL BENJAMIN · 2019 to 2023
$2.6M
Sodium Nitrite Supplementation for Improving Physiological Function in Patients with Chronic Kidney DiseaseK01DK115524 · NIDDK · UNIVERSITY OF COLORADO · PI ROSSMAN, MATTHEW J · 2018 to 2023
$1.1M
Equol Supplementation for Improving Vascular Function in Postmenopausal Women with CKD: Efficacy and Mechanistic Role of GPERK01HL179491 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Ester Soo Jung Oh · 2025 to 2026
$400k
Chronic MitoQ Supplementation for Improving Cerebrovascular Function in Older AdultsF31AG087709 · NIA · UNIVERSITY OF COLORADO · PI Sanna Darvish · 2024 to 2026
$129k
Metabolome and Microbiome Profiling in Response to Dietary Interventions in Patients with ADPKDF32DK132836 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI STEELE, CORTNEY NICOLE · 2022 to 2023
$111k
American Heart Association 24CDA1274418Ludeman Family Center for Women's Health Research Women's Health Innovation Scholar AwardNCATS NIH HHS UM1 TR004399NHLBI NIH HHS K01 HL179491NIA NIH HHS F31 AG087709NIA NIH HHS F31AG087709NIA NIH HHS R01 AG066730NIA NIH HHS R01AG066730NIDDK NIH HHS 1F32DK132836-01ANIDDK NIH HHS 5T32DK007135-46NIDDK NIH HHS F32 DK132836NIDDK NIH HHS K01 DK115524NIDDK NIH HHS K01DK115524NIDDK NIH HHS R01 DK121516NIDDK NIH HHS R01DK121516NIDDK NIH HHS R01 DK130266NIDDK NIH HHS R01DK130266NIDDK NIH HHS T32 DK007135
6 · The paper itself

Abstract

key pointsIn Systolic Blood Pressure Intervention Trial Memory and Cognition in Decreased Hypertension, men with CKD had a higher risk of dementia than women, whereas no sex differences were observed among participants without CKD. In the physiologic study, men with CKD exhibited greater cerebrovascular stiffness, slower processing speed, and worse executive function versus women. Men with nondialysis CKD may have higher dementia risk than women, potentially associated with greater cerebrovascular stiffness.

backgroundWomen face higher risk of dementia than men in the general population, with some studies also reporting female sex is associated with higher dementia risk in patients receiving hemodialysis. However, it is unclear whether this sex-specific pattern extends to nondialysis CKD, in whom the pathophysiology of cognitive impairment may differ due to the absence of dialysis-related factors. Accordingly, we examined sex differences in older adults with and without nondialysis CKD, who participated in Systolic Blood Pressure Intervention Trial Memory and Cognition in Decreased Hypertension (SPRINT MIND). Using pooled data from our clinical studies, we further explored mechanisms underlying sex-specific cognitive decline by cross-sectionally comparing cerebrovascular and cognitive measures between sexes, separately for adults with and without nondialysis CKD.

methodsSPRINT MIND analyses used Cox proportional hazard models to compare sex differences in the risk of cognitive outcomes (probable dementia [PD], mild cognitive impairment, and their composite) in men and propensity score-matched women, separately for CKD and non-CKD. A total of 681 men with CKD were propensity score-matched to 681 women with CKD and 1253 men without CKD to 1253 women without CKD. In physiologic clinical study, including participants with CKD (81 men, 34 women) and without CKD (35 men, 64 women), we compared middle cerebral artery pulsatility index (MCA PI; measure of cerebrovascular stiffness assessed by transcranial Doppler) and cognitive function (trails A and B times) by sex, separately for CKD and non-CKD.

resultsIn SPRINT MIND, men with CKD had higher risk of PD/mild cognitive impairment composite (hazard ratio, 1.49; 95% confidence interval, 1.10 to 2.02) and PD alone (hazard ratio, 1.98; 95% confidence interval, 1.23 to 3.17) than women, with no sex differences in non-CKD. In the physiologic clinical study, men with CKD exhibited higher MCA PI and slower trails A and B times than women, with no sex differences in non-CKD. Across all participants, lower eGFR was associated with greater MCA PI more strongly in men ( r =-0.34; P < 0.001) than women ( r =-0.23; P = 0.03) and with slower trails B time ( r =-0.22; P = 0.02) in men only.

conclusionsMen with nondialysis CKD may have higher dementia risk than women, potentially associated with greater cerebrovascular stiffness. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: NCT04040959 .

Indexed as

Cognitive DysfunctionDementiaRenal Insufficiency, ChronicAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedRisk FactorsSex FactorsVascular StiffnessCKDcognitiondementia

Identifiers

PMID41264372
PMCPMC12959741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.